People around the world are suffering from diabetes. There are about 415 million who have the condition and it is steadily increasing. It is bound to even rise up to 642 million by 2040. It is considered as the top mortality cause of 2030.
Forbes explains that this is indeed a global healthcare issue that needs to be seriously addressed. While we’re waiting for innovations in medicine as well as treatment, here are several tools that can help people manage the disease.
Having Diabetes Is No Longer Going To Be A Life Sentence
Here are the top five ways that Frost & Sullivan’s transformational health program analysts predict diabetes management will change in the future. Read more…
Post Gazette tells us about a new device that currently represents good news for people with diabetes. The device is about an “artificial pancreas.” This is part of the technology that encourages automated blood-glucose control. People with Type 1 diabetes should rejoice.
The FDA approved the device last September and it will most likely reach the market next spring. Medtronic created the device that combines two technologies. A continuously functioning glucose monitor for blood sugar and a pump that steadily provides insulin.
New Device Represents Breakthrough In Type 1 Diabetes Management
Officially, it’s called the “Medtronic MiniMed 670G hybrid closed loop insulin delivery system.” But don’t let that mouthful hide its importance. Read more…
With the increasing availability of the digital programs over the Internet in this day and age, health companies are offering virtual diabetes programs. It may be in the form of an app, web education or online coaching. This is to support weight loss and management of lifestyle behaviours.
These companies are worth something. They’re all becoming popular with consumers, sparking interest. They have efficacy studies to back their progress and they have scored partnerships with providers.
In-Depth: With Diabetes Prevention Programs, digital programs are close to earning CMS’s approval
But to fully embrace digital programs, CMS will need more information across three key areas, Brickman said: how they are conducted, how well do they work, and what are the risks and challenges to running a digital diabetes prevention program? Read more…
With these in mind, we are hoping for progress and continuous inventions for the discovery of treatment. Though this is far in the future, recent developments prove to be promising.